Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

This advertisement has not loaded yet, but your article continues below. Images of the tests showed what appeared to be a BMW sedan being destroyed and old models of tanks being blown up More than ...

Devoted to the world of classical stringed instruments such as the violin, viola, cello and double bass, The Strad has been an essential read for musicians since 1890. The Strad covers all the latest ...